These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6396766)

  • 1. Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
    Jones SE; Brooks RJ; Takasugi BJ; Garewal HS; Giordano GF; Ketchel SJ; Jackson R; Heusinkveld RS; Kemmer SR; Moon TE
    Recent Results Cancer Res; 1984; 96():133-40. PubMed ID: 6396766
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
    Jones SE; Moon TE
    Recent Results Cancer Res; 1984; 96():148-54. PubMed ID: 6396768
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
    Rivkin SE; Glucksberg H; Foulkes M
    Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
    Rossi A; Brambilla C; Valagussa P; Bonadonna G
    Recent Results Cancer Res; 1984; 96():178-83. PubMed ID: 6396772
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
    Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
    Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
    [No Abstract]   [Full Text] [Related]  

  • 6. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
    Tormey C
    Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer.
    Buzdar AU; Smith TL; Marcus CE; Hortobagyi GN; Blumenschein GR
    Recent Results Cancer Res; 1984; 96():141-7. PubMed ID: 6396767
    [No Abstract]   [Full Text] [Related]  

  • 10. Review: experience of randomized trials without surgical controls.
    Tormey DC
    Recent Results Cancer Res; 1984; 96():184-7. PubMed ID: 6396773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy using the CMF regimen (cyclophosphamide, methotrexate, and 5-fluorouracil) and the VAC protocol (vincristine, adriamycin and cyclophosphamide) in patients with advanced breast cancer].
    Glińska H; Zulichowska J; Radziszewska J; Sukiennik-Siuda M; Trabka E
    Nowotwory; 1987; 37(3):251-61. PubMed ID: 3438177
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
    Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso R
    Anticancer Res; 1990; 10(6):1743-5. PubMed ID: 2126683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for node-negative breast cancer patients.
    Bonadonna G; Zambetti M; Valagussa P
    Recent Results Cancer Res; 1989; 115():175-9. PubMed ID: 2516350
    [No Abstract]   [Full Text] [Related]  

  • 15. CMF adjuvant programs at the Milan Cancer Institute.
    Bonadonna G; Rossi A; Tancini G; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1984; 96():66-73. PubMed ID: 6549356
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
    Tormey DC; Gray R; Falkson HC; Gilchrist K; Abeloff MD; Falkson G
    Recent Results Cancer Res; 1993; 127():185-96. PubMed ID: 8502815
    [No Abstract]   [Full Text] [Related]  

  • 18. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update.
    Blumenschein GR; Buzdar AU; Hortobagyi GN
    Recent Results Cancer Res; 1984; 96():129-32. PubMed ID: 6528087
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy in high-risk breast cancer patients with ten or more positive lymph nodes.
    Jaiyesimi IA; Buzdar AU
    Am J Clin Oncol; 1992 Apr; 15(2):180-3. PubMed ID: 1313203
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials in advanced breast cancer.
    Schwartsmann G; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):595-7. PubMed ID: 3653182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.